The PE Ratio as of September 2024 (TTM) for Absci Corporation (ABSI) is -4.32

According to Absci Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -4.32. This represents a change of 13.02% compared to the average of -3.82 of the last 4 quarters.

Absci Corporation (ABSI) Historical PE Ratio (quarterly & annually)

How has ABSI PE Ratio performed in the past?

The mean historical PE Ratio of Absci Corporation over the last ten years is -88.48. The current -4.32 PE Ratio has changed 388.25% with respect to the historical average. Over the past ten years (40 quarters), ABSI's PE Ratio was at its highest in in the June 2023 quarter at -0.84. The PE Ratio was at its lowest in in the March 2020 quarter at -183.52.

Absci Corporation (ABSI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Absci Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Absci Corporation (ABSI) Average PE Ratio

How has ABSI PE Ratio performed in the past?

The current PE Ratio of Absci Corporation (ABSI) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Absci Corporation (ABSI) PE Ratio vs. Peers

How is ABSI’s PE Ratio compared to its peers?

Absci Corporation’s PE Ratio is less than Recursion Pharmaceuticals, Inc. (-3.82), less than Affimed N.V. (-0.66), greater than Sana Biotechnology, Inc. (-4.82), less than Relay Therapeutics, Inc. (-2.57), less than Exscientia plc (-3.65), greater than VectivBio Holding AG (-7.94), greater than Zura Bio Limited (-9.00), less than Elevation Oncology, Inc. (-0.93), greater than Icosavax, Inc. (-8.27), less than AVROBIO, Inc. (2.07), less than Hepion Pharmaceuticals, Inc. (-0.15), less than Precision BioSciences, Inc. (4.08), less than Caribou Biosciences, Inc. (-1.26), less than ContraFect Corporation (-0.11), less than Graphite Bio, Inc. (-0.13), greater than Day One Biopharmaceuticals, Inc. (-7.39), less than Acumen Pharmaceuticals, Inc. (-2.06), less than X4 Pharmaceuticals, Inc. (7.41), less than Inozyme Pharma, Inc. (-3.48),

Build a custom stock screener for Absci Corporation (ABSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Absci Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Absci Corporation (ABSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Absci Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.